• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Johnson & Johnson MedTech launches mobile simulator for breast procedures

Johnson & Johnson MedTech launches mobile simulator for breast procedures

January 16, 2026 By Sean Whooley

This is the logo of Johnson & Johnson MedTech.Johnson & Johnson (NYSE: JNJ) announced that it launched the Arbrea Breast Simulator Surgeon App for Mentor in the U.S.

The digital consultation tool, available on tablets and smartphones, helps plastic surgeons personalize planning for patients. It enables the vizualization of potential outcomes during breast augmentation consultations.

According to Johnson & Johnson, most plastic surgeons still use physical sizers and before-and-after galleries to guide conversations about outcomes when it comes to breast procedures. J&J’s Arbrea Breast Simulator Surgeon App for Mentor helps to deliver a personalized 3D simulation in about 60 seconds.

The company says the process enhances clinical discussions in real time and helps patients visualize how different options could look.

Johnson & Johnson said a recent study underscored the need for solutions that better help patients visualize outcomes during consultations. Published in Aesthetic Surgery Journal Open Forum, the study found that, while 68.4% of women surveyed considered the procedure, only 17.5% underwent the procedure. Just 7.2% of those consulted proceeded to surgery.

Two separate studies showed the positive impact of the Abrea app on the consultation experience, the company said. In one study, patients rated the app 3.4 out of 4 for how closely it matched their final surgical result. In another, clinics reported conversion rates that reached as high as 87% for consultations using the app.

“The Arbrea Breast Simulator Surgeon App for Mentor gives surgeons an easy-to use digital tool that helps transform their augmentation consultations into clear, patient-centered conversations,” said Alenka Brzulja, worldwide president, Aesthetics & Reconstruction, MedTech, Johnson & Johnson. “Many women spend months or even years considering breast augmentation. By allowing them to visualize potential outcomes in seconds, this app brings clarity to the decision-making process, supports a more confident, personal choice, and has been shown to help patients feel ready to make decisions more quickly.”

Filed Under: Cosmetic/Aesthetic, Digital Health, Health Technology, Software / IT, Surgical, Women's Health Tagged With: Johnson & Johnson, Johnson & Johnson MedTech

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy